<?xml version="1.0" encoding="UTF-8"?>
<ref id="B93-ijms-21-03474">
 <label>93.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Guillon</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Clement</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sebille</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Rivain</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Chou</surname>
    <given-names>C.F.</given-names>
   </name>
   <name>
    <surname>Ruvoen-Clouet</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Le Pendu</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies</article-title>
  <source>Glycobiology</source>
  <year>2008</year>
  <volume>18</volume>
  <fpage>1085</fpage>
  <lpage>1093</lpage>
  <pub-id pub-id-type="doi">10.1093/glycob/cwn093</pub-id>
  <?supplied-pmid 18818423?>
  <pub-id pub-id-type="pmid">18818423</pub-id>
 </element-citation>
</ref>
